Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Vaginal development and sexual functioning in young women after stem cell transplantation, chemotherapy, and/or radiotherapy for childhood hematological diseases

Abstract

To study vaginal development and sexual functioning in young women after childhood hemopoietic stem cell transplantation (HSCT) and radio/chemotherapy. Observational case–control study on 30 young sexually active women survived after HSCT and/or radio/chemotherapy for childhood malignancies or hematologic diseases and 48 controls matched for age. Female Sexual Function Index was lower (median 24.05, IQR = 17.30–28.30 vs. 29.00, IQR = 25.30–31.40, p = 0.001), Female Sexual Distress Scale higher (median 16.00, IQR = 8.00–23.00 vs. 2.00, IQR = 0.00–4.00, p < 0.001), vaginal length shorter (mean difference = 21.1 mm; 95% CI = 19.3–23, p < .001) and vaginal maturation index worst in cases than in controls. Subjects treated by irradiation before HSCT had lower FSFI (median 21.85, IQR = 9.60–31.10 vs. 24.90, IQR = 17.30–28.30) and shorter vaginal length (median 45.55, IQR = 42.60–45.80 vs. 50.10, IQR = 45.30–52.90) compared to those who had not received conditioning treatment (p-values = 0.004 and p = 0.05, respectively). Compared to untreated subjects, women receiving hormonal replacement therapy had higher overall FSFI (p = 0.02), lower FSDS (0.04), and better VMI. Gonadotoxic therapies have adverse effects on vaginal development, sexual functioning, and distress in young females. Hormonal replacement therapy should be shortly considered after main gonodatoxic treatments to improve vaginal and sex health.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Bevans M, El-Jawahri A, Tierney DK, Wiener L, Wood WA, Hoodin F, et al. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report. Biol Blood Marrow Transplant. 2017;23:538–51.

    Article  Google Scholar 

  2. Guida M, Castaldi MA, Rosamilio R, Giudice V, Orio F, Selleri C. Reproductive issues in patients undergoing hematopoietic stem cell transplantation: an update. J Ovarian Res. 2016;9:72.

    Article  Google Scholar 

  3. Watson M, Wheatley K, Harrison GA, Zittoun R, Gray RG, Goldstone AH, et al. Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone: analysis of the MRC AML 10 trial. Cancer. 1999;86:1231–9.

    Article  CAS  Google Scholar 

  4. Thygesen KH, Schjodt I, Jarden M. The impact of hematopoietic stem cell transplantation on sexuality: a systematic review of the literature. Bone Marrow Transplant. 2012;47:716–24.

    Article  CAS  Google Scholar 

  5. Frey Tirri B, Hausermann P, Bertz H, Greinix H, Lawitschka A, Schwarze CP, et al. Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD. Bone Marrow Transplant. 2015;50:3–9.

    Article  CAS  Google Scholar 

  6. Mazzarello S, Hutton B, Ibrahim MFK, Jacobs C, Shorr R, Smith S, et al. Management of urogenital atrophy in breast cancer patients: a systematic review of available evidence from randomized trials. Breast Cancer Res Treat. 2015;152:1–8.

    Article  CAS  Google Scholar 

  7. Hess R, Austin RM, Dillon S, Chang CC, Ness RB. Vaginal maturation index self-sample collection in mid-life women: acceptability and correlation with physician-collected samples. Menopause. 2008;15:726–9.

    Article  Google Scholar 

  8. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26:191–208.

    Article  CAS  Google Scholar 

  9. Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005;31:1–20.

    Article  Google Scholar 

  10. Raggio GA, Butryn ML, Arigo D, Mikorski R, Palmer SC. Prevalence and correlates of sexual morbidity in long-term breast cancer survivors. Psychol Health. 2014;29:632–50.

    Article  Google Scholar 

  11. Derogatis LR, Rosen R, Leiblum S, Burnett A, Heiman J. The Female Sexual Distress Scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther. 2002;28:317–30.

    Article  Google Scholar 

  12. Derogatis L, Clayton A, Lewis-D’Agostino D, Wunderlich G, Fu Y. Validation of the Female Sexual Distress Scale-revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med. 2008;5:357–64.

    Article  Google Scholar 

  13. Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol. 1998;92:722–7.

    CAS  PubMed  Google Scholar 

  14. Metzger ML, Meacham LR, Patterson B, Casillas JS, Constine LS, Hijiya N, et al. Female reproductive health after childhood, adolescent, and young adult cancers: guidelines for the assessment and management of female reproductive complications. J Clin Oncol. 2013;31:1239–47.

    Article  Google Scholar 

  15. Bath LE, Wallace WH, Critchley HO. Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation. BJOG. 2002;109:107–14.

    Article  Google Scholar 

  16. Meirow D, Biederman H, Anderson RA, Wallace WH. Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol. 2010;53:727–39.

    Article  Google Scholar 

  17. Bruner DW, Lanciano R, Keegan M, Corn B, Martin E, Hanks GE. Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma. Int J Radiat Oncol Biol Phys. 1993;27:825–30.

    Article  CAS  Google Scholar 

  18. Sarpel U, Palmer SK, Dolgin SE. The incidence of complete androgen insensitivity in girls with inguinal hernias and assessment of screening by vaginal length measurement. J Pediatr Surg. 2005;40:133–6.

    Article  Google Scholar 

  19. Barnhart KT, Izquierdo A, Pretorius ES, Shera DM, Shabbout M, Shaunik A. Baseline dimensions of the human vagina. Hum Reprod. 2006;21:1618–22.

    Article  Google Scholar 

  20. Humphreys CT, Tallman B, Altmaier EM, Barnette V. Sexual functioning in patients undergoing bone marrow transplantation: a longitudinal study. Bone Marrow Transplant. 2007;39:491–6.

    Article  CAS  Google Scholar 

  21. Lee Y, Lim MC, Kim SI, Joo J, Lee DO, Park SY. Comparison of quality of life and sexuality between cervical cancer survivors and healthy women. Cancer Res Treat. 2016;48:1321–9.

    Article  Google Scholar 

  22. White ID, Sangha A, Lucas G, Wiseman T. Assessment of sexual difficulties associated with multi-modal treatment for cervical or endometrial cancer: A systematic review of measurement instruments. Gynecol Oncol. 2016;143:664–73.

    Article  Google Scholar 

  23. Domenici L, Palaia I, Giorgini M, Piscitelli VP, Tomao F, Marchetti C, et al. Sexual health and quality of life assessment among ovarian cancer patients during chemotherapy. Oncology. 2016;91:205–10.

    Article  Google Scholar 

  24. Baser RE, Li Y, Carter J. Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors. Cancer. 2012;118:4606–18.

    Article  Google Scholar 

  25. Yoon JY, Park HJ, Ju HY, Yoon JH, Chung JS, Hwang SH, et al. Gonadal and sexual dysfunction in childhood cancer survivors. Cancer Res Treat. 2017;122:2268–76.

    Google Scholar 

  26. Syrjala KL, Kurland BF, Abrams JR, Sanders JE, Heiman JR. Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years. Blood. 2008;111:989–96.

    Article  CAS  Google Scholar 

  27. Li Z, Mewawalla P, Stratton P. Sexual health in hematopoietic stem cell transplant recipients. Cancer. 2015;121:4124–31.

    Article  Google Scholar 

  28. Sundberg KK, Lampic C, Bjork O, Arvidson J, Wettergren L. Positive and negative consequences of childhood cancer influencing the lives of young adults. Eur J Oncol Nurs. 2009;13:164–70.

    Article  Google Scholar 

  29. Syrjala KL, Langer SL, Abrams JR, Storer BE, Martin PJ. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol. 2005;23:6596–606.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elena Locatelli.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Beneventi, F., Locatelli, E., Simonetta, M. et al. Vaginal development and sexual functioning in young women after stem cell transplantation, chemotherapy, and/or radiotherapy for childhood hematological diseases. Bone Marrow Transplant 53, 1157–1164 (2018). https://doi.org/10.1038/s41409-018-0149-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41409-018-0149-x

This article is cited by

Search

Quick links